汉瑞祥(HSIC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

HSIC 汉瑞祥

盘前交易 03-06 05:12:24 EST

80.17

-0.41

-0.51%

最高80.93	最低79.40	成交量129.25万
今开79.43	昨收80.58	日振幅1.90%
总市值91.96亿	流通市值81.73亿	总股本1.15亿
成交额1.04亿	换手率1.27%	流通股本1.02亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"HSIC","market":"US","secType":"STK","nameCN":"汉瑞祥","latestPrice":80.17,"timestamp":1772744400000,"preClose":80.58,"halted":0,"volume":1292514,"delay":0,"changeRate":-0.005088111193844584,"floatShares":101946134,"shares":114704121,"eps":3.27,"marketStatus":"盘前交易","change":-0.41,"latestTime":"03-06 05:12:24 EST","open":79.43,"high":80.93,"low":79.4,"amount":103538410.83708,"amplitude":0.018987,"askPrice":83.23,"askSize":56,"bidPrice":78.61,"bidSize":56,"shortable":3,"etf":0,"ttmEps":3.27,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772807400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":80.17,"postHourTrading":{"tag":"盘后","latestPrice":80.58,"preClose":80.17,"latestTime":"18:30 EST","volume":28508,"amount":2291854.48,"timestamp":1772753422004,"change":0.41,"changeRate":0.005114,"amplitude":0.005114},"volumeRatio":0.822894622164349,"impliedVol":0.3185,"impliedVolPercentile":0.404},"requestUrl":"/m/hq/s/HSIC","defaultTab":"news","newsList":[{"id":"1120162923","title":"异动解读 | 汉瑞祥盘中大涨6.17%，季度利润超预期与新CEO任命提振市场信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1120162923","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120162923?lang=zh_cn&edition=full","pubTime":"2026-02-24 22:35","pubTimestamp":1771943711,"startTime":"0","endTime":"0","summary":"汉瑞祥今日盘中股价大幅上涨6.17%，引发了市场的高度关注。公司高管同时透露，美国医疗及牙科分销业务增长约半数由销量提升驱动，且本季度患者流量保持稳定并呈现积极态势，这些积极因素共同推动了投资者对公司前景的乐观预期。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HSIC"],"gpt_icon":0},{"id":"1119328137","title":"汉瑞祥高管表示本季度患者流量保持稳定且趋向积极","url":"https://stock-news.laohu8.com/highlight/detail?id=1119328137","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119328137?lang=zh_cn&edition=full","pubTime":"2026-02-24 21:19","pubTimestamp":1771939154,"startTime":"0","endTime":"0","summary":"汉瑞祥高管在电话会议中透露，本季度患者流量整体保持稳定，并呈现积极向好态势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","HSIC","BK4588","BK4585"],"gpt_icon":0},{"id":"1154035965","title":"汉瑞祥高管：美国医疗及牙科分销业务增长约半数由销量提升驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=1154035965","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154035965?lang=zh_cn&edition=full","pubTime":"2026-02-24 21:15","pubTimestamp":1771938910,"startTime":"0","endTime":"0","summary":"汉瑞祥公司高管在电话会议中透露，其在美国市场的医疗及牙科分销业务增长中，约一半的驱动力来自于销售量的显著提升。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","HSIC","BK4588","BK4175"],"gpt_icon":0},{"id":"1172936954","title":"弗雷德·洛厄里将携20年赛默飞世尔经验出任新CEO，下周正式履新——电话会议确认","url":"https://stock-news.laohu8.com/highlight/detail?id=1172936954","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172936954?lang=zh_cn&edition=full","pubTime":"2026-02-24 21:09","pubTimestamp":1771938566,"startTime":"0","endTime":"0","summary":"汉瑞祥公司于电话会议中宣布，弗雷德·洛厄里将于下周正式加入公司并出任首席执行官。洛厄里在生命科学领域巨头赛默飞世尔拥有长达二十年的丰富从业经历，其专业背景与领导经验将为汉瑞祥的战略发展注入新动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","HSIC","BK4175","BK4585"],"gpt_icon":0},{"id":"1191076973","title":"汉瑞祥第四季度调整后每股收益1.34美元，超出IBES预估的1.3美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191076973","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191076973?lang=zh_cn&edition=full","pubTime":"2026-02-24 19:17","pubTimestamp":1771931873,"startTime":"0","endTime":"0","summary":"汉瑞祥公布第四季度每股收益为0.85美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK4175","HSIC"],"gpt_icon":0},{"id":"1101418653","title":"财报前瞻｜汉瑞祥本季度营收预计增1.51%，机构观点偏温和","url":"https://stock-news.laohu8.com/highlight/detail?id=1101418653","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101418653?lang=zh_cn&edition=full","pubTime":"2026-02-17 11:01","pubTimestamp":1771297309,"startTime":"0","endTime":"0","summary":"汉瑞祥将于2026年02月24日美股盘前发布财报，市场预期本季度营收与盈利维持温和增长节奏，关注利润率弹性与业务结构优化进展。市场一致预期显示，汉瑞祥本季度营收预计为33.45亿美元，同比增长1.51%；调整后每股收益预计为1.30美元，同比增长7.67%；EBIT预计为2.49亿美元，同比增长2.44%。结合一致预期本季度公司整体营收同比增长1.51%，意味着分销主业有望延续温和修复，但节奏较上季度的同比5.20%有所收敛，反映季节性影响与渠道去化趋于理性。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻｜汉瑞祥本季度营收预计增1.51%，机构观点偏温和","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSIC"],"gpt_icon":0},{"id":"1132553818","title":"汉瑞祥第三季度调整后每股收益为1.38美元，略超IBES预期的1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1132553818","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132553818?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:32","pubTimestamp":1763569951,"startTime":"0","endTime":"0","summary":"11月4日——汉瑞祥第三季度调整后的净收入为1.67亿美元，高于IBES预计的1.574亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","BK4588","BK4585","HSIC"],"gpt_icon":0},{"id":"1150887150","title":"异动解读 | 汉瑞祥盘中大涨11.51%，强劲业绩和上调全年指引提振投资者信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1150887150","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150887150?lang=zh_cn&edition=full","pubTime":"2025-11-04 23:24","pubTimestamp":1762269869,"startTime":"0","endTime":"0","summary":"医疗设备分销商汉瑞祥周二盘中大涨11.51%，股价走势引发市场广泛关注。该公司发布的2025年第三季度财报表现亮眼，并上调了全年业绩指引，成为推动股价上涨的主要因素。除了强劲的财务业绩外，汉瑞祥还宣布了一项价值创造计划，预计未来几年将为公司带来超过2亿美元的经营收入改善。此外，公司董事会批准了一项战略合作协议的修订，允许KKR将其在汉瑞祥的持股比例提高至19.9%，这进一步增强了投资者对公司前景的信心。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HSIC"],"gpt_icon":0},{"id":"1154066979","title":"异动解读 | 汉瑞祥盘前大涨5.20%，业绩超预期且上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1154066979","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154066979?lang=zh_cn&edition=full","pubTime":"2025-11-04 20:12","pubTimestamp":1762258348,"startTime":"0","endTime":"0","summary":"牙科产品分销商汉瑞祥今日盘前大涨5.20%，引发市场关注。该公司发布了2025年第三季度财报，业绩表现亮眼，并上调了全年业绩指引。根据公司公告，汉瑞祥第三季度收入达到33.4亿美元，高于分析师平均预期的32.8亿美元。除了强劲的财务业绩外，汉瑞祥还宣布了一项价值创造计划，预计未来几年将为公司带来超过2亿美元的经营收入改善。这些积极因素共同推动了汉瑞祥股价的显著上涨。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HSIC"],"gpt_icon":0},{"id":"1196623159","title":"汉瑞祥：董事会已批准战略合作协议的修订，允许KKR将其HSIC股票持有比例提高至19.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1196623159","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196623159?lang=zh_cn&edition=full","pubTime":"2025-11-04 19:05","pubTimestamp":1762254318,"startTime":"0","endTime":"0","summary":"汉瑞祥：董事会已批准战略合作协议的修订，允许KKR将其HSIC股票持有比例提高至19.9%","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","BK4588","BK4585","HSIC"],"gpt_icon":0},{"id":"1166079728","title":"汉瑞祥：宣布价值创造计划，预计未来几年将带来超过2亿美元的经营收入改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1166079728","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166079728?lang=zh_cn&edition=full","pubTime":"2025-11-04 19:04","pubTimestamp":1762254253,"startTime":"0","endTime":"0","summary":"汉瑞祥：宣布价值创造计划，预计未来几年将带来超过2亿美元的经营收入改善","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","BK4585","HSIC","BK4588"],"gpt_icon":0},{"id":"1137387016","title":"汉瑞祥：财年展望不包含重组开支、摊销费用和网络安全事件的保险索赔恢复","url":"https://stock-news.laohu8.com/highlight/detail?id=1137387016","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137387016?lang=zh_cn&edition=full","pubTime":"2025-11-04 19:03","pubTimestamp":1762254194,"startTime":"0","endTime":"0","summary":"汉瑞祥：财年展望不包含重组开支、摊销费用和网络安全事件的保险索赔恢复","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSIC","BK4588","BK4175","BK4585"],"gpt_icon":0},{"id":"1104500189","title":"汉瑞祥发布2025年第三季度创纪录的财务业绩并上调全年非GAAP每股收益指导","url":"https://stock-news.laohu8.com/highlight/detail?id=1104500189","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104500189?lang=zh_cn&edition=full","pubTime":"2025-11-04 19:03","pubTimestamp":1762254187,"startTime":"0","endTime":"0","summary":"汉瑞祥发布2025年第三季度创纪录的财务业绩并上调全年非GAAP每股收益指导","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","HSIC","BK4175","BK4588"],"gpt_icon":0},{"id":"1186853341","title":"汉瑞祥与Biomerica达成市场服务协议，推广Biomerica的Infoods® Ibs测试","url":"https://stock-news.laohu8.com/highlight/detail?id=1186853341","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186853341?lang=zh_cn&edition=full","pubTime":"2025-10-16 20:19","pubTimestamp":1760617155,"startTime":"0","endTime":"0","summary":"汉瑞祥与Biomerica达成市场服务协议，推广Biomerica的Infoods® Ibs测试。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMRA","BK4585","BK4175","BK4588","HSIC","BK4082"],"gpt_icon":0},{"id":"2516376037","title":"亨利香恩服务2024财年实现净利润3.90亿美元，同比减少6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516376037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516376037?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:00","pubTimestamp":1740758456,"startTime":"0","endTime":"0","summary":"3月1日，亨利香恩服务公布财报，公告显示公司2024财年净利润为3.90亿美元，同比减少6.25%；其中营业收入为126.73亿美元，同比增加2.71%，每股基本收益为3.08美元。从资产负债表来看，亨利香恩服务总负债53.81亿美元，其中短期债务7.81亿美元，资产负债比为1.90，流动比率为1.43。机构评级：截至2025年3月1日，当前有13家机构对亨利香恩服务目标价做出预测，其中目标均价为80.23美元，其中最低目标价为55.00美元，最高目标价为90.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000147a2581848&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000147a2581848&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HSIC"],"gpt_icon":0},{"id":"2514695618","title":"瑞银：维持Henry Schein(HSIC.US)评级，由中性调整至中性评级, 目标价由83.00美元调整至80.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514695618","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514695618?lang=zh_cn&edition=full","pubTime":"2025-02-27 02:41","pubTimestamp":1740595279,"startTime":"0","endTime":"0","summary":"瑞银：维持Henry Schein(HSIC.US)评级，由中性调整至中性评级, 目标价由83.00美元调整至80.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/27024148414159.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["HSIC"],"gpt_icon":0},{"id":"1144996800","title":"异动解读 | 汉瑞祥(HSIC)盘中大跌5.01%,业绩预期疲软拖累股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1144996800","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144996800?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:16","pubTimestamp":1740496609,"startTime":"0","endTime":"0","summary":"医疗保健产品分销商汉瑞祥(Henry Schein)今日盘中股价大跌5.01%,引发市场关注。\n\n汉瑞祥公布的2025财年指引显示,预计当年每股利润为4.80美元至4.94美元,增长幅度为1%至4%,低于分析师预期的4.99美元。此外,汉瑞祥预计2025财年总销售额较2024财年增长约2%至4%,也低于市场预期。\n\n数据显示,持续通胀导致客户预算受到挤压,需求放缓是拖累汉瑞祥业绩的主因。由于较高的价格,客户不得不取消或推迟非紧急手术,如牙齿矫正和高端牙科修复等,影响了公司核心的牙科产品销售。汉瑞祥表示,虽然预计2025年牙科和医疗市场将略有改善,但仍低于预期,因而对业绩前景较为谨慎。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | 汉瑞祥(HSIC)盘中大跌5.01%,业绩预期疲软拖累股价","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HSIC"],"gpt_icon":0},{"id":"2514015867","title":"亨利香恩服务盘中异动 股价大跌5.01%报73.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514015867","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514015867?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:14","pubTimestamp":1740496499,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时14分，亨利香恩服务股票出现波动，股价大幅下挫5.01%。截至发稿，该股报73.75美元/股，成交量57.6508万股，换手率0.46%，振幅8.69%。亨利香恩服务股票所在的医疗销售行业中，整体涨幅为0.41%。其相关个股中，Cosmos Health Inc.、欧麦斯-麦能医疗、Synergy Chc Corp.涨幅较大，Cosmos Health Inc.、欧麦斯-麦能医疗、亨利香恩服务较为活跃，换手率分别为1.51%、0.70%、0.47%，振幅较大的相关个股有Cosmos Health Inc.、亨利香恩服务、欧麦斯-麦能医疗，振幅分别为12.17%、8.73%、5.32%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231459a25391df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231459a25391df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4175","HSIC","BK4585"],"gpt_icon":0},{"id":"1189847272","title":"Henry Schein 2024年第四季度调整后每股收益（EPS）为1.19美元，低于预期的1.21美元，销售额为31.8亿美元，低于预期的33.0亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1189847272","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189847272?lang=zh_cn&edition=full","pubTime":"2025-02-25 19:13","pubTimestamp":1740481991,"startTime":"0","endTime":"0","summary":"Henry Schein  报告季度每股收益为1.19美元，低于分析师普遍预期的1.21美元，差幅为1.65%。相比去年同期的每股收益0.66美元，这一数据增长了80.3%。以上内容来自Benzinga Earnings专栏，原文如下：Henry Schein  reported quarterly earnings of $1.19 per share which missed the analyst consensus estimate of $1.21 by 1.65 percent. This is a 80.3 percent increase over earnings of $0.66 per share from the same period last year.  The company reported quarterly sales of $3.18 billion which missed the analyst consensus estimate of $3.30 billion by 3.53 percent.  This is a 5.37 perce","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSIC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.henryschein.com","stockEarnings":[{"period":"1week","weight":-0.016},{"period":"1month","weight":0.0961},{"period":"3month","weight":0.089},{"period":"6month","weight":0.1547},{"period":"1year","weight":0.1219},{"period":"ytd","weight":0.0607}],"compareEarnings":[{"period":"1week","weight":-0.0116},{"period":"1month","weight":-0.0119},{"period":"3month","weight":-0.0064},{"period":"6month","weight":0.0526},{"period":"1year","weight":0.1685},{"period":"ytd","weight":-0.0009}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Henry Schein, Inc.是特拉华州的一家公司。该公司是一家由人和技术组成的网络为医疗保健专业人员提供解决方案的公司。该公司认为，这家全球最大的医疗保健产品和服务提供商主要面向办公室牙科和医疗从业者，以及替代护理场所。凭借94年的保健产品分销经验，该公司在牙科和医疗市场建立了一套庞大的小型、中型和大型客户，服务于全球超过一百万的客户，包括牙科诊所、实验室、医师诊所和门诊手术中心，以及政府、机构保健诊所和替代护理诊所。","yearOnYearQuotes":[{"month":1,"riseRate":0.516129,"avgChangeRate":0.016432},{"month":2,"riseRate":0.548387,"avgChangeRate":0.000011},{"month":3,"riseRate":0.645161,"avgChangeRate":0.035943},{"month":4,"riseRate":0.466667,"avgChangeRate":0.005457},{"month":5,"riseRate":0.7,"avgChangeRate":0.040088},{"month":6,"riseRate":0.5,"avgChangeRate":0.006461},{"month":7,"riseRate":0.566667,"avgChangeRate":0.009908},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.014595},{"month":9,"riseRate":0.566667,"avgChangeRate":-0.000801},{"month":10,"riseRate":0.4,"avgChangeRate":-0.003723},{"month":11,"riseRate":0.666667,"avgChangeRate":0.026311},{"month":12,"riseRate":0.645161,"avgChangeRate":0.027203}],"exchange":"NASDAQ","name":"汉瑞祥","nameEN":"Henry Schein"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"汉瑞祥(HSIC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供汉瑞祥(HSIC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"汉瑞祥,HSIC,汉瑞祥股票,汉瑞祥股票老虎,汉瑞祥股票老虎国际,汉瑞祥行情,汉瑞祥股票行情,汉瑞祥股价,汉瑞祥股市,汉瑞祥股票价格,汉瑞祥股票交易,汉瑞祥股票购买,汉瑞祥股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"汉瑞祥(HSIC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供汉瑞祥(HSIC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}